HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 225.20
Day range
kr 215.00 - kr 225.80
Year range
kr 160.00 - kr 486.00
Market cap
6.79B SEK
Avg Volume
196.97K
P/E ratio
270.39
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 226.14M | -0.62% |
Operating expense | 127.26M | -19.77% |
Net income | 31.65M | -13.02% |
Net profit margin | 13.99 | -12.51% |
Earnings per share | 1.01 | -38.37% |
EBITDA | 51.09M | 82.02% |
Effective tax rate | 23.17% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 292.09M | -29.70% |
Total assets | 2.37B | -1.19% |
Total liabilities | 260.65M | 5.97% |
Total equity | 2.11B | — |
Shares outstanding | 31.50M | — |
Price to book | 3.36 | — |
Return on assets | 3.87% | — |
Return on capital | 4.13% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 31.65M | -13.02% |
Cash from operations | 86.93M | 40.02% |
Cash from investing | -66.46M | 40.33% |
Cash from financing | -2.55M | -6.68% |
Net change in cash | 12.15M | 135.25% |
Free cash flow | 8.66M | 122.67% |
About
Founded
1998
Website
Employees
198
